trial
as of 2026-07-01NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
NCTId NCT06653829
at a glance
— · Completed
Enrollment 20 (actual)
Sponsored by North Shore Therapeutics, Inc.
Primary completion 2024-08-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-11-06
Primary completion
2024-08-31
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
North Shore Therapeutics, Inc.Lead Sponsor
Investigators
1
Sunny X Tang, M.D.Principal Investigator
Sites
1 total
Rochester, United States
Facts & assertions
4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2024-08-31
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
indication
indication
indication
investigator
person